News
A team of researchers from the San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET, Milan), led by Nadia Coltella and ...
A team of physicians recently reported the successful treatment of refractory autoimmune neuropathies through the infusion of ...
A novel chimeric antigen receptor T-cell therapy may benefit patients with B-cell lymphomas who previously relapsed following CD19-directed CAR-T, according to results of a phase 1 study.More than 80% ...
A team of researchers from the San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET, Milan) , led by Nadia Coltella and Luigi Naldini, has ...
A Martin County family with a child fighting rare cancer is getting help from the community to get treatment abroad.
Penn's leading scientists in CAR-T and mRNA, Carl June and Drew Weissman, are among the company's founders.
Melbourne scientists have shown for the first time how a “revolutionary” blood cancer treatment could be tweaked to also cure ...
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $69.0, a high ...
13h
News-Medical.Net on MSNLeukemia-on-a-chip offers breakthrough in personalized cancer treatmentA team of researchers led by NYU Tandon School of Engineering's Weiqiang Chen has developed a miniature device that could ...
By 2030, the cell and gene therapy market is projected to be worth £76.03bn, and logistics is essential in realising the ...
Sabic to close UK cracker, plastics recycler Novoloop raises funds, Kymera strikes molecular glue deal, and more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results